Skip to main content
. 2021 Jun 26;11:360. doi: 10.1038/s41398-021-01482-9

Fig. 1. Incidence of new onset metabolic syndrome according to SSEP over one year of psychotropic treatment in the adult population.

Fig. 1

Analysis was performed in the adult population (25 ≤ age< 65) and was adjusted by age, sex, first available BMI, diagnosis, risk of psychotropic drug-induced weight gain, using a Cox proportional hazards model (n = 366). The number at risk at baseline: 168 High SSEP vs 198 Low SSEP, at 3 months: 98 High SSEP vs 109 Low SSEP, at 6 months: 47 High SSEP vs 54 Low SSEP, at 9 months: 29 High SSEP vs 29 Low SSEP, at 12 months: 16 High SSEP vs 16 Low SSEP. High and Low SSEP groups were defined as SSEP over (≥61.8) vs under (<61.8) median SSEP, respectively.